The policy of the our Sustainable Development Strategy is to "accelerate the listing of new drugs to prolong the lives of patients and make society better." We wish to uphold sustainable core values of "innovative R&D, professional attitude, trustworthy, reliability, and create major impacts". Under the three major scopes of "build a green life, care for and be a friend to society, and cooperative industrial growth" to establish seven major topics for implementing sustainable development strategies. The second major topics are "environment conservation", "social participation", "talent training and retention", "innovative R&D", "cyber security", "corporate governance", and "co-prosper with industry". Since establishment, PharmaEngine not only focuses on corporate governance and operation performance, we have also been proactively moving forward towards environment sustainability and social engagement. We hope through the implementation of our corporate sustainability strategies to create changes and impacts on the environment, social, and governance aspects.

Looking into the future, PharmaEngine will continue to keep integrity as the foundation, flexible operation and professional skills as the main focus, and human-centered approach as the core, to promote new drug R&D activities that align with the spirit of ESG. We wish to deepen international cooperation, leverage global R&D resources, accelerate new product development and commercialization, establish a globally competitive and diversified product portfolio, and set out to achieve the obligation of sustainable social responsibility ultimately.